Objective-To examine the composition of illicitly manufactured "ecstasy" tablets sold on the UK drugs market. Methods-Analysis by gas chromatography of 25 jl) were analysed by gas chromatography with flame ionisation detection. Samples were injected onto a silated glass (1.5 m x 4 mm internal diameter) column packed with 2% potassium hydroxide and 10% Apiezon L on Chromosorb-w-(AW) 100-120 mesh. Nitrogen at a flow rate of 60 ml/min was the carrier gas; hydrogen flow was at 1.0 kg/cm2 and air flow 1.2 kg/cm2. Analysis for the presence of amphetamine, methylamphetamine, methyldioxyamphetamine (MDA), MDMA, methyldioxyethamphetamine (MDEA), and a range of other drugs took place over a temperature gradient held at 1 55°C for 10 min followed by an increase of 8°C/min to a final temperature of 195°C. Temperatures of the injection and detector ports were 200°C and 190°C respec-tively. Extracts of tablets and quality control samples were measured against known concentrations of standards (10 gg/ml) and the detector recalibrated after every 10th sample. Paracetamol and caffeine were assayed by enzyme colorimetric assay and ketamine by using an in-house gas chromatography-mass spectrometry procedure.
Over the last decade data from surveys of the general population and in both school and university samples have indicated that the use of illicit drugs has increased, particularly among the young.' Some have attributed this general increase to specific increases in the use of drugs such as amphetamines, "ecstasy", and LSD, commonly referred to as "dance drugs" or "recreational drugs".' 8 9 While drugs such as LSD and amphetamines have a well documented history,"' comparatively little is known about recreational use of ecstasy in the UK. Even less is known about the compositions of tablets sold as ecstasy.
In its pure form, the street drug ecstasy contains the active ingredient 3,4-methylenedioxymethamphetamine (MDMA) but ecstasy by no means always contains MDMA. [11] [12] [13] Since illegal drugs are typically produced in clandestine laboratories, there are few, if any, controls over their manufacture. Street samples of ecstasy could contain analogues of MDMA, other drugs, or no active ingredients. '4 Buying ecstasy is a gamble, given that it exists in many forms, under different brand names sold at different prices. ' (10 jl) were analysed by gas chromatography with flame ionisation detection. Samples were injected onto a silated glass (1.5 m x 4 mm internal diameter) column packed with 2% potassium hydroxide and 10% Apiezon L on Chromosorb-w-(AW) 100-120 mesh. Nitrogen at a flow rate of 60 ml/min was the carrier gas; hydrogen flow was at 1.0 kg/cm2 and air flow 1.2 kg/cm2. Analysis for the presence of amphetamine, methylamphetamine, methyldioxyamphetamine (MDA), MDMA, methyldioxyethamphetamine (MDEA), and a range of other drugs took place over a temperature gradient held at 1 55°C for 10 min followed by an increase of 8°C/min to a final temperature of 195°C. Temperatures of the injection and detector ports were 200°C and 190°C respectively. Extracts of tablets and quality control samples were measured against known concentrations of standards (10 gg/ml) and the detector recalibrated after every 10th sample. Paracetamol and caffeine were assayed by enzyme colorimetric assay and ketamine by using an in-house gas chromatography-mass spectrometry procedure.
Results
Each of the ecstasy samples in the present study was in tablet form, except for one, rhubarb and custard, which was a red and yellow capsule containing powder. Weights and dimensions of the tablets varied (see table 1 ). Of the 25 tablets handed in, doves (small white tablets embossed with a dove shape on one side) were the most common (n=7) and all contained MDMA (range 19-140 mg). One of these dove tablets also contained traces of caffeine. A further five tablets (love heart, MDMA tablet, New Yorker, purple heart, and the rhubarb and custard capsule) also contained doses of MDMA (range 2-105 mg). One of these five tablets (purple heart) contained traces of caffeine and another (MDMA tablet) contained 39 mg of caffeine. The only capsule, Note: ketamine was detected using an in house gas chromatography-mass spectrometry assay (using selective ion monitoring). Ephedrine elutes at 9.55 min on the gas chromatography assay for ecstasy. Paracetamol was assayed by enzyme colorimetric assay (limit of detection 0.01 mmol/1).
rhubarb and custard, contained traces of both amphetamine and methamphetamine (see Our survey suggests that there are three main areas of concern for users of ecstasy. The first is the variability in tablet constituents. The second, variation in quantities of active ingredients, and the third, the variability of both ingredients and quantity in tablets with the same brand name.
Tablets are as likely to contain no active ingredients as they are to contain MDMA or MDEA. Contrary to user accounts,'5 ecstasy tablets are unlikely to contain cocaine, heroin, or other opiates. Including these ingredients in tablets is unlikely to be economic for drug manufacturers of ecstasy.'2 White tablets embossed with a dove appeared to be the most commonly sold products on the ecstasy market,'5 as they were in our own sample. All the dove tablets we analysed had MDMA as the main active ingredient, but there was more than a sevenfold difference in the concentration of MDMA. Highly variable concentrations of MDMA and related compounds in tablets may cause problems, particularly for those who consume several tablets over a period of a few hours; coupled with a high degree of polydrug use on the dance drug scene, this is perhaps the biggest danger ecstasy users face.
"Brand" name does not provide any guarantee of either ingredient or concentration. Some brand names may be more popular with consumers than others, and used as a marketing ploy to suggest either tablets of good quality or particular ingredients.'2 15 19 20 Indeed, it has been reported that the popular name for MDMA was originally changed from "empathy" to ecstasy. Although the former is a more accurate description of the drug's effects, the latter was believed to sell better.2' Health education officials should publicise the dangers of using ecstasy tablets in recreational environments and a working knowledge of the street name of the range of tablets sold as ecstasy may be useful.
Our survey has some lessons for a number of health care professionals. For those in accident and emergency (A&E) departments (where growing numbers of patients who have reportedly taken ecstasy are seen) it is important to note the range of agents that may be consumed as ecstasy. Most of the ecstasy tablets that we (and others) have analysed contained MDMA or some other analogue. For patients admitted to A&E departments after an ecstasy overdose, it is important to bear this in mind. Other ingredients in ecstasy tablets are less of a concern. The other two principal ingredients in the tablets we analysed were paracetamol and ketamine. Paracetamol was not present in concentrations likely to cause harm, even if individuals took several tablets in one evening. Two of the 25 tablets we analysed contained the anaesthetic agent ketamine. The quantity of drug in the two tablets, 186 mg and 197 mg respectively, is equivalent to about 2.5 mg ketamine/kg body weight (for a 70 kg individual). Ketamine undergoes extensive first pass metabolism in the liver with the result that only about one sixth of an oral dose reaches the circulation.22 Ketamine is usually administered intramuscularly, and a dose of 0.5 mg/kg will alter the pain threshold, in other words, has some analgesic effect. This dose is similar to what would be obtained if someone swallowed either of the two ketamine containing tablets we analysed. One report even suggests that oral doses of 0.5 mg/kg will induce analgesia. 23 However, others state that 0.5 mg/kg is not satisfactory for producing analgesia.22 Intramuscular injection of 10 mg/kg will produce anaesthesia for 10-25 minutes sufficient for surgery. Psychic sequelae appears to be dose related, 24 and is reported to be markedly reduced if ketamine is used at subanaesthetic doses. 23 Individuals would have to consume a number of the ketamine containing tablets we analysed before being rendered unconscious. However, the consumption of several tablets together may leave someone ataxic.
For health educators, there are several messages. Users of ecstasy are involved in a form of lottery with no guarantee that the tablets they purchase will contain MDMA (let alone a quantity sufficient to induce the experience they are seeking). The great variation in concentrations of active ingredients seems to present considerable risks for certain individuals. It is still unclear why a minority of users die after ingestion of just one or even several tablets of ecstasy."4 18 Evidence points to some individual sensitivity to MDMA or its related analogues, and there is likely to be an increased risk for all concerned if several tablets are consumed in a short period of time. There is some limited evidence (only two cases) of differences between a male and a female in the metabolism of MDMA, with the MDA metabolite more rapidly cleared in a male than a female.25 Individuals given a racemic mixture of MDMA appear to metabolise the "S" enantiomer more rapidly than the "R" form. 26 The tablets we analysed came from all parts of the UK and a number had ingredients other than MDMA or its analogues. None of these "non-ecstasy" tablets will provide an "ecstasy experience" and consumers should not take several tablets in the hope of achieving this state. This practice could result in consumption of a high dose of another drug (such as ketamine) which, by inducing a state of near anaesthesia, could result in a fall, or more significantly, an individual collapsing, apparently unconscious. Ecstasy users need to be reminded that there is no guarantee about the quality or likely effects of the drugs they consume.
